IVIG Treatment and Prognosis in Guillain–Barré Syndrome

By Doorn Pieter   Kuitwaard Krista   Walgaard Christa   Koningsveld Rinske   Ruts Liselotte   Jacobs Bart  

Journal of Clinical Immunology, Vol. 30, Iss. 1, 2010-05 ,pp. : 74-78

Springer Publishing Company

Access to resources Recommend Favorite

A retrospective survey of the quality of reports and their correlates among randomized controlled trials of immunotherapy for Guillain-Barré syndrome

By Lu Liming   Luo Gaoquan   Xiao Fang  

Immunotherapy, Vol. 5, Iss. 8, 2013-08 ,pp. : 829-836

Future Medicine

Access to resources Recommend Favorite

Recovery from Guillain–Barré Syndrome Is Associated with Increased Levels of Neutralizing Autoantibodies to Interferon-&ggr;

By Elkarim R.A.   Dahle C.   Mustafa M.   Press R.   Zou L-P.   Ekerfelt C.   Ernerudh J.   Link H.   Bakhiet M.  

Clinical Immunology, Vol. 88, Iss. 3, 1998-09 ,pp. : 241-248

Academic Press

Access to resources Recommend Favorite

Increased Circulating Th17 Cell Populations and Elevated CSF Osteopontin and IL-17 Concentrations in Patients with Guillain-Barré Syndrome

By Han Rong   Cheng Yue   Zhou Shan   Guo Hong   He Rui   Chi Li   Zhang Li  

Journal of Clinical Immunology, Vol. 34, Iss. 1, 2014-01 ,pp. : 94-103

Springer Publishing Company

Access to resources Recommend Favorite

Intravenous Immunoglobulin Therapy in Antiphospholipid Syndrome

By Konova Emiliana  

Clinical Reviews in Allergy and Immunology, Vol. 29, Iss. 3, 2005-12 ,pp. : 229-236

Humana Press, Inc

Access to resources Recommend Favorite